Published in Hypertension on March 08, 2004
Peripheral blood gene expression profiling for cardiovascular disease assessment. Genomic Med (2008) 1.18
Pharmacogenetics in drug development. Philos Trans R Soc Lond B Biol Sci (2005) 0.91
Transcriptomic biomarkers of cardiovascular disease. Prog Cardiovasc Dis (2012) 0.88
Prediction of ischemic events on the basis of transcriptomic and genomic profiling in patients undergoing carotid endarterectomy. Mol Med (2012) 0.87
Increased proinflammatory and oxidant gene expression in circulating mononuclear cells in older adults: amelioration by habitual exercise. Physiol Genomics (2011) 0.86
A neural network model for constructing endophenotypes of common complex diseases: an application to male young-onset hypertension microarray data. Bioinformatics (2009) 0.82
Primary hypertension in children and adolescents is an immuno-metabolic disease with hemodynamic consequences. Curr Hypertens Rep (2013) 0.77
Pre-existing hypertension dominates γδT cell reduction in human ischemic stroke. PLoS One (2014) 0.76
Short-term erythropoietin treatment does not substantially modulate monocyte transcriptomes of patients with combined heart and renal failure. PLoS One (2012) 0.75
Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalities. Pediatr Nephrol (2015) 0.75
Toward a comprehensive atlas of the physical interactome of Saccharomyces cerevisiae. Mol Cell Proteomics (2007) 7.93
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep (2003) 4.52
Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes (2004) 4.24
Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med (2009) 4.20
Functional organization of the S. cerevisiae phosphorylation network. Cell (2009) 3.15
Genome-wide analyses reveal RNA polymerase II located upstream of genes poised for rapid response upon S. cerevisiae stationary phase exit. Mol Cell (2005) 3.15
Protein interaction verification and functional annotation by integrated analysis of genome-scale data. Mol Cell (2002) 3.07
An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet (2005) 3.04
FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet (2012) 2.74
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res (2007) 2.69
Monitoring global messenger RNA changes in externally controlled microarray experiments. EMBO Rep (2003) 2.51
Poised RNA polymerase II gives pause for thought. Cell (2008) 2.48
Functional overlap and regulatory links shape genetic interactions between signaling pathways. Cell (2010) 2.29
Mediator expression profiling epistasis reveals a signal transduction pathway with antagonistic submodules and highly specific downstream targets. Mol Cell (2005) 2.21
Genome-wide location of the coactivator mediator: Binding without activation and transient Cdk8 interaction on DNA. Mol Cell (2006) 2.16
Protein restriction in lactation confers nephroprotective effects in the male rat and is associated with increased antioxidant expression. Am J Physiol Regul Integr Comp Physiol (2007) 2.15
A high resolution protein interaction map of the yeast Mediator complex. Nucleic Acids Res (2004) 2.15
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP. Eur Respir J (2012) 2.12
The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J (2004) 2.09
Red cell distribution width is associated with physical inactivity and heart failure, independent of established risk factors, inflammation or iron metabolism; the EPIC-Norfolk study. Int J Cardiol (2013) 2.05
The specificity and topology of chromatin interaction pathways in yeast. Mol Cell (2011) 2.04
From structure to systems: high-resolution, quantitative genetic analysis of RNA polymerase II. Cell (2013) 1.87
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis Rheum (2007) 1.86
A central role for TFIID in the pluripotent transcription circuitry. Nature (2013) 1.82
Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum (2002) 1.79
Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: a population-based analysis. Eur Urol (2010) 1.65
Assessment of renal autoregulation. Am J Physiol Renal Physiol (2007) 1.62
Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension (2007) 1.59
Assessing adrenal insufficiency of corticosteroid secretion using free versus total cortisol levels in critical illness. Intensive Care Med (2011) 1.58
Gene expression profiling of early intervertebral disc degeneration reveals a down-regulation of canonical Wnt signaling and caveolin-1 expression: implications for development of regenerative strategies. Arthritis Res Ther (2013) 1.57
Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis. J Hypertens (2007) 1.56
Distinct promoter dynamics of the basal transcription factor TBP across the yeast genome. Nat Struct Mol Biol (2009) 1.56
In control: systematic assessment of microarray performance. EMBO Rep (2004) 1.55
Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant (2003) 1.54
Atorvastatin reduces sympathetic activity in patients with chronic kidney disease. J Hypertens (2011) 1.52
Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2007) 1.50
High cumulative incidence of cancer in patients with cardio-renal-anaemia syndrome. Eur J Heart Fail (2010) 1.45
Can exercise prevent preeclampsia? J Hypertens (2010) 1.40
Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat Chem Biol (2009) 1.40
Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int (2004) 1.40
Cooperative action of NC2 and Mot1p to regulate TATA-binding protein function across the genome. Genes Dev (2008) 1.38
Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One (2012) 1.36
Effect of supplementation with zinc and other micronutrients on malaria in Tanzanian children: a randomised trial. PLoS Med (2011) 1.36
Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol (2004) 1.36
Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. Nat Clin Pract Nephrol (2008) 1.30
Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase. Hypertension (2005) 1.29
Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol (2003) 1.28
Haemodynamic influences on kidney oxygenation: clinical implications of integrative physiology. Clin Exp Pharmacol Physiol (2013) 1.28
Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. Cancer Res (2006) 1.27
E2F7 represses a network of oscillating cell cycle genes to control S-phase progression. Nucleic Acids Res (2011) 1.26
Mot1p is essential for TBP recruitment to selected promoters during in vivo gene activation. EMBO J (2002) 1.25
Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. Transplantation (2002) 1.25
Causes and consequences of increased sympathetic activity in renal disease. Hypertension (2004) 1.24
Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II. Hum Mutat (2004) 1.22
Two distinct repressive mechanisms for histone 3 lysine 4 methylation through promoting 3'-end antisense transcription. PLoS Genet (2012) 1.21
Predicting gene function through systematic analysis and quality assessment of high-throughput data. Bioinformatics (2004) 1.21
Gcn4 misregulation reveals a direct role for the evolutionary conserved EKC/KEOPS in the t6A modification of tRNAs. Nucleic Acids Res (2011) 1.20
In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent. Nephrol Dial Transplant (2005) 1.20
A consensus of core protein complex compositions for Saccharomyces cerevisiae. Mol Cell (2010) 1.19
CTGF inhibits BMP-7 signaling in diabetic nephropathy. J Am Soc Nephrol (2008) 1.19
STAT activation and differential complex formation dictate selectivity of interferon responses. Acta Biochim Pol (2007) 1.18
Determination of fibroblast growth factor 23. Ann Clin Biochem (2009) 1.16
Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Physiol Heart Circ Physiol (2004) 1.12
PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells. Neoplasia (2013) 1.11
Oxidative stress in obstructive nephropathy. Int J Exp Pathol (2010) 1.10
Adaptable gene-specific dye bias correction for two-channel DNA microarrays. Mol Syst Biol (2009) 1.09
Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Nephrol Dial Transplant (2010) 1.09
End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells. Am J Physiol Renal Physiol (2007) 1.09
The renal angiotensin system does not reveal its secrets with a cross-sectional analysis of urinary angiotensinogen levels. J Hypertens (2013) 1.09
Genomics and epigenomics of clear cell renal cell carcinoma: recent developments and potential applications. Cancer Lett (2013) 1.08
Getting the message across: opportunities and obstacles in effective communication in hypertension care. J Hypertens (2012) 1.08
Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol (2003) 1.08
Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system? J Hypertens (2009) 1.08
Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension (2007) 1.07
Improved genome-wide localization by ChIP-chip using double-round T7 RNA polymerase-based amplification. Nucleic Acids Res (2008) 1.07
Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol (2005) 1.06
Alpha+ -thalassemia protects against anemia associated with asymptomatic malaria: evidence from community-based surveys in Tanzania and Kenya. J Infect Dis (2008) 1.06
Distinct role of Mediator tail module in regulation of SAGA-dependent, TATA-containing genes in yeast. EMBO J (2011) 1.05
Critical roles for a genetic code alteration in the evolution of the genus Candida. EMBO J (2007) 1.04
Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model. Am J Physiol Heart Circ Physiol (2010) 1.04